2017
DOI: 10.21767/2573-4482.100064
|View full text |Cite
|
Sign up to set email alerts
|

Anticoagulation in the Surgical Management of Peripheral Arterial Embolic Disease

Abstract: Introduction: Low-molecular-weight heparin has been showed to be effective for veno-occlusive disease and acute coronary syndrome. It is frequently used for peripheral arterial embolic disease but this is not a licensed use and there is little evidence or guidelines for this. This article aims to review the peri-operative use and outcomes of LMWH and unfractionated heparin (UFH) following arterial embolectomy in a district general hospital.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 11 publications
0
1
0
Order By: Relevance
“…This is usually done to prolong time to surgery secondary to delayed patient presentation and delay in patient transfer to proper tertiary care centre. 11 The 51 out of 75 patients showed improvement in the post op period. Distal pulsations were palpable in the immediate post op with restoration of normal limb function.…”
Section: Discussionmentioning
confidence: 93%
“…This is usually done to prolong time to surgery secondary to delayed patient presentation and delay in patient transfer to proper tertiary care centre. 11 The 51 out of 75 patients showed improvement in the post op period. Distal pulsations were palpable in the immediate post op with restoration of normal limb function.…”
Section: Discussionmentioning
confidence: 93%